In about 70 percent of all clinical decisions, in-vitro diagnostics (IVD) is a very important healthcare resource not only for disease detection but also for monitoring a patient's condition, deciding the line of treatment, seeing that the treatment is complete, or to decide whether there is a cure, or for prognosis.
In India, the laboratory and diagnostic business is at a crucial juncture, as it is changing from a profit-driven area to a customer-centric stream, and is in the course of becoming the soul of the healthcare sector, given the rising need of early detection and monitoring demanded today by several life-threatening diseases.
In recent times, there has been plenty of advances in the IVD space, whether at the genomics, the molecular diagnostics, the technology, instrumentation, materials used, or the software solution levels. The Covid-19 pandemic accelerated this advancement. The global in-vitro diagnostics (IVD) market size is projected to reach $96.0 billion by 2025 from $84.5 billion in 2020, according to a ResearchAnd Markets report. According to the same research firm, the India IVD (Instruments & Reagents) market is likely to reach $1.8 billion mark by 2025.
The emerging technologies
Thanks to the demands of the Covid era, polymerase chain reaction (PCR) testing has become mainstream with its ability to quickly churn out results using the same sample for multiple detections, informs Chandrashekhar Nair, Co-Founder and CTO, Molbio Diagnostics.
هذه القصة مأخوذة من طبعة January 2023 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة January 2023 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.